Category: Life Sciences
Global Life Sciences
-
Healthcare Workforce Management Systems
... reach US$8.0 Billion by 2030, growing at a CAGR of 13.3% over the analysis period 2023-2030. Software Component, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach ... Read More
-
Histology and Cytology
... by 2030, growing at a CAGR of 14.4% over the analysis period 2023-2030. Cytology, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$50.6 Billion by the ... Read More
-
Hysteroscopes
... of 5.3% over the analysis period 2023-2030. Rigid Hysteroscopes, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$238.5 Million by the end of the analysis period. ... Read More
-
Nanosensors
... of 59.0% over the analysis period 2023-2030. Healthcare End-Use, one of the segments analyzed in the report, is expected to record a 61.8% CAGR and reach US$14.1 Billion by the end of the analysis period. ... Read More
-
Oncology Molecular Diagnostics
... by 2030, growing at a CAGR of 11.1% over the analysis period 2023-2030. Breast Cancer, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.9 Billion by ... Read More
-
Optical Emission Spectroscopy (OES)
... reach US$1.2 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. OES Equipment, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach ... Read More
-
Sperm Banks
... at a CAGR of 5.3% over the analysis period 2023-2030. Sperm Storage Service, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$4.2 Billion by the end ... Read More
-
Spine Biologics
... at a CAGR of 4.4% over the analysis period 2023-2030. Spinal Allografts, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Statins
... of 1.8% over the analysis period 2023-2030. Synthetic Statins, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$12.2 Billion by the end of the analysis period. ... Read More
-
Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers
... Barriers estimated at US$5.0 Billion in the year 2023, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Hemostats, one of the segments analyzed in ... Read More
-
Antithrombin
... of 5.2% over the analysis period 2023-2030. Therapeutics Application, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$847.5 Million by the end of the analysis period. ... Read More
-
Stem Cell Assays
... by 2030, growing at a CAGR of 17.9% over the analysis period 2023-2030. Instruments Component, one of the segments analyzed in the report, is expected to record a 18.4% CAGR and reach US$6.1 Billion by ... Read More
-
Surgical Fluid Disposal Products
... reach US$4.8 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. Containers, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.0 ... Read More
-
Surgical Staplers
... at a CAGR of 5.0% over the analysis period 2023-2030. Manual Surgical Staplers, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$4.6 Billion by the end ... Read More
-
Family Planning Centers
... by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. Birth Control Clinics, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$4.5 Billion ... Read More
-
Psychiatric and Substance Abuse Hospitals
... is expected to reach US$42.0 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Alcoholism Rehabilitation Hospitals, one of the segments analyzed in the report, is expected to record a ... Read More
-
Spring and Wire Products
... reach US$82.0 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Springs, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$47.0 ... Read More
-
Albumin
... of 3.7% over the analysis period 2023-2030. Human Serum Albumin, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$902.4 Million by the end of the analysis ... Read More
-
Veterinary Dentistry Instruments & Equipment
... is expected to reach US$468.0 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Oral Examination Instrumentation, one of the segments analyzed in the report, is expected to record a ... Read More
-
Airway/Lung Stents
... at a CAGR of 5.4% over the analysis period 2023-2030. Tracheal Stents, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$96.6 Million by the end of ... Read More
-
Orthobiologics
... of 4.1% over the analysis period 2023-2030. Viscosupplementation, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth ... Read More
-
Orthopedic Surgical Robots
... by 2030, growing at a CAGR of 40.3% over the analysis period 2023-2030. Knee Surgery End-Use, one of the segments analyzed in the report, is expected to record a 37.8% CAGR and reach US$6.6 Billion ... Read More
-
Orthopedic Software
... at a CAGR of 6.4% over the analysis period 2023-2030. Orthopedic PACS Software, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$219.4 Million by the end ... Read More
-
Knee Cartilage Repair
... by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Arthroscopic Chondroplasty Application, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$3.4 Billion ... Read More
-
Prescription Drugs Market
... USD 2,151.63 billion by 2032, exhibiting a CAGR of 7.1% during the forecast period of 2024-2032. The COVID-19 pandemic disrupted supply chains and delayed scientific trials in the Prescription Drugs Market, main to shortages of ... Read More
Research Assistance
